ARTICLE | Distillery Therapeutics
Neurology
October 20, 2016 7:00 AM UTC
In vitro and mouse studies identified a dual PDE-5/HDAC inhibitor that could help treat AD. Chemical synthesis and in vitro testing of molecules that combined structural features of known HDAC and PDE...